Exact Mass: 444.1573

Exact Mass Matches: 444.1573

Found 163 metabolites which its exact mass value is equals to given mass value 444.1573, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetracycline

(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

C22H24N2O8 (444.1533)


Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic (-)-Tetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=60-54-8 (retrieved 2024-09-27) (CAS RN: 60-54-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Doxycycline

(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

C22H24N2O8 (444.1533)


Doxycycline is only found in individuals that have used or taken this drug. It is a synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum). [PubChem]Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis. Doxycycline prevents the normal function of the apicoplast of Plasmodium falciparum, a malaria causing organism. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Fluticasone

Fluticasone

C22H27F3O4S (444.1582)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine

(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine

C23H26NO8+ (444.1658)


   

15-(4-Iodophenyl)pentadecanoic acid

Omega-(4-iodophenyl)pentadecanoic acid, 125I-labeled CPD

C21H33IO2 (444.1525)


   

Epitetracycline

4-(Dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboximidate

C22H24N2O8 (444.1533)


Sanclomycine, also known as achromycin or 4 epitetracycline, belongs to the class of organic compounds known as tetracyclines. These are polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups. Based on a literature review very few articles have been published on Sanclomycine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Epitetracycline is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Epitetracycline is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Epitetracycline hydrochloride. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23313-80-6 (retrieved 2024-10-30) (CAS RN: 23313-80-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

fluticasone

1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-14,17-dihydroxy-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

C22H27F3O4S (444.1582)


   

Halometasone

4-chloro-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

C22H27ClF2O5 (444.1515)


   

Sibiricaphenone

Sibiricaphenone

C20H28O11 (444.1632)


   
   

Manglieside B

Manglieside B

C20H28O11 (444.1632)


   
   

Hyuganoside IV

Hyuganoside IV

C20H28O11 (444.1632)


   

Chlorohyssopifolin D

Chlorohyssopifolin D

C21H29ClO8 (444.1551)


   

(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine

(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine

C23H26NO8 (444.1658)


   

Raltegravir

Raltegravir (MK-0518)

C20H21FN6O5 (444.1557)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AJ - Integrase inhibitors D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

   

2-Chloroflumethasone

2-Chloroflumethasone

C22H27ClF2O5 (444.1515)


   
   

alpha-D-Xylopyranosyl-(1鈥樏傗垎4)-beta-D-glucopyranosyl-(1鈥樏傗垎6)-D-glucose

alpha-D-Xylopyranosyl-(1鈥樏傗垎4)-beta-D-glucopyranosyl-(1鈥樏傗垎6)-D-glucose

C16H28O14 (444.1479)


   

13??,21-Dihydroxyeurycomanol

13??,21-Dihydroxyeurycomanol

C20H28O11 (444.1632)


   

demethyleugenol 4-O-beta-D-xylopyranosyl-(1?6)-O-beta-D-glucopyranoside

demethyleugenol 4-O-beta-D-xylopyranosyl-(1?6)-O-beta-D-glucopyranoside

C20H28O11 (444.1632)


   

2-hydroxycinnamic alcohol 2-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|cinnacasolide B

2-hydroxycinnamic alcohol 2-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|cinnacasolide B

C20H28O11 (444.1632)


   

1-(2-hydroxy-6-methylphenyl)ethanone 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside IV

1-(2-hydroxy-6-methylphenyl)ethanone 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside IV

C20H28O11 (444.1632)


   

4-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranosyl acetophenone

4-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranosyl acetophenone

C20H28O11 (444.1632)


   

[4-(beta-D-glucopyranosyloxy)benzyl] 2,3-dihydroxy-3-methylbutanoate

[4-(beta-D-glucopyranosyloxy)benzyl] 2,3-dihydroxy-3-methylbutanoate

C20H28O11 (444.1632)


   

4-allyl-2-hydroxyphenyl 1-O-beta-D-apiosyl-(1->6)-beta-D-glucopyranoside

4-allyl-2-hydroxyphenyl 1-O-beta-D-apiosyl-(1->6)-beta-D-glucopyranoside

C20H28O11 (444.1632)


   

6-angeloyl-antirrinoside

6-angeloyl-antirrinoside

C20H28O11 (444.1632)


   

(2S)-2-phenylpropionyl 6-O-beta-D-xylopyranisyl-beta-D-glucopyranoside

(2S)-2-phenylpropionyl 6-O-beta-D-xylopyranisyl-beta-D-glucopyranoside

C20H28O11 (444.1632)


   

6-senecioyl-antirrinoside

6-senecioyl-antirrinoside

C20H28O11 (444.1632)


   
   

longusone A

longusone A

C27H24O6 (444.1573)


   
   

Doxycycline

Doxycycline

C22H24N2O8 (444.1533)


Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3678

   

Tetracycline

Tetracycline

C22H24N2O8 (444.1533)


A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

Raltegravir (MK-0518)

Raltegravir (MK-0518)

C20H21FN6O5 (444.1557)


   

HALOMETASONE MONOHYDRATE

HALOMETASONE MONOHYDRATE

C22H27ClF2O5 (444.1515)


   

Doxycycline (anhydrous)

Doxycycline (anhydrous)

C22H24N2O8 (444.1533)


   

C20H28O11_Pentanedioic acid, 3-hydroxy-3-methyl-, [4-(beta-D-glucopyranosyloxy)phenyl]methyl methyl ester

NCGC00380171-01_C20H28O11_Pentanedioic acid, 3-hydroxy-3-methyl-, [4-(beta-D-glucopyranosyloxy)phenyl]methyl methyl ester

C20H28O11 (444.1632)


   

Halometasone

Halometasone

C22H27ClF2O5 (444.1515)


D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C29629 - Combination Medication > C29639 - Topical Preparation > C29505 - Topical Corticosteroid D000893 - Anti-Inflammatory Agents D003879 - Dermatologic Agents

   
   

Asp His Ser Ser

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Asp Ser His Ser

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Asp Ser Ser His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

His Asp Ser Ser

(3S)-3-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

His Ser Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

His Ser Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]butanedioic acid

C16H24N6O9 (444.1605)


   
   
   
   
   
   
   

Ser Asp His Ser

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Ser Asp Ser His

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Ser His Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Ser His Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]butanedioic acid

C16H24N6O9 (444.1605)


   

Ser Ser Asp His

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C16H24N6O9 (444.1605)


   

Ser Ser His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C16H24N6O9 (444.1605)


   

4-Epitetracycline

4-Epitetracycline

C22H24N2O8 (444.1533)


   

(S)-Tamsulosin Hydrochloride

5-[(2S)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,hydrochloride

C20H29ClN2O5S (444.1486)


   
   

Boc-L-Asp(Bzl)-ONp

Boc-L-Asp(Bzl)-ONp

C22H24N2O8 (444.1533)


   

Tamsolusin Hydrochloride

Tamsolusin Hydrochloride

C20H29ClN2O5S (444.1486)


   
   

diethyl 4-[2,6-bis(ethoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate

diethyl 4-[2,6-bis(ethoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate

C22H24N2O8 (444.1533)


   

4-Defluoro-4-hydroxy Gefitinib

2-chloro-4-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]phenol

C22H25ClN4O4 (444.1564)


   

(4S,5S,6S)-6-[(1R)-2-[tert-butyl(diphenyl)silyl]oxy-1-hydroxyethyl]-5-hydroxy-2-oxo-1,3-dioxane-4-carbaldehyde

(4S,5S,6S)-6-[(1R)-2-[tert-butyl(diphenyl)silyl]oxy-1-hydroxyethyl]-5-hydroxy-2-oxo-1,3-dioxane-4-carbaldehyde

C23H28O7Si (444.1604)


   

epi-Doxycycline

epi-Doxycycline

C22H24N2O8 (444.1533)


   

4-Epidoxycycline

4-Epidoxycycline

C22H24N2O8 (444.1533)


   

4-Epioxytetracycline

4-Epioxytetracycline

C22H24N2O8 (444.1533)


   

4-Methylphenyl 6-deoxy-2-O-(phenylmethyl)-1-thio-beta-L-galactopyranoside 3,4-diacetate

4-Methylphenyl 6-deoxy-2-O-(phenylmethyl)-1-thio-beta-L-galactopyranoside 3,4-diacetate

C24H28O6S (444.1607)


   

Tamsulosin hydrochloride

Tamsulosin hydrochloride

C20H29ClN2O5S (444.1486)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin hydrochloride ((R)-(-)-YM12617) is an inhibitor of α1-adrenergic receptor. Tamsulosin hydrochloride is used for the research of prostatic hyperplasia. Tamsulosin hydrochloride attenuates abdominal aortic aneurysm growth in animal models[1].

   

N-Fmoc-5-fluoro-L-tryptophan

N-Fmoc-5-fluoro-L-tryptophan

C26H21FN2O4 (444.1485)


   

Tetracycline zwitterion

Tetracycline zwitterion

C22H24N2O8 (444.1533)


A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of tetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

4-acetamido-N-[4-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-thiazolyl]benzamide

4-acetamido-N-[4-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-thiazolyl]benzamide

C25H24N4O2S (444.162)


   

3-[(4Z)-5-oxo-3-phenyl-4-[(4-phenylphenyl)methylidene]pyrazol-1-yl]benzoic acid

3-[(4Z)-5-oxo-3-phenyl-4-[(4-phenylphenyl)methylidene]pyrazol-1-yl]benzoic acid

C29H20N2O3 (444.1474)


   

N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide

N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide

C22H25ClN4O4 (444.1564)


   

4-[(4-Acetyl-2-methoxyphenyl)methoxy]-3-methoxybenzoic acid [1-(carbamoylamino)-1-oxopropan-2-yl] ester

4-[(4-Acetyl-2-methoxyphenyl)methoxy]-3-methoxybenzoic acid [1-(carbamoylamino)-1-oxopropan-2-yl] ester

C22H24N2O8 (444.1533)


   

3-Benzyl-2-(benzylimino)-5-(3,4-dimethoxybenzylidene)-1,3-thiazolidin-4-one

3-Benzyl-2-(benzylimino)-5-(3,4-dimethoxybenzylidene)-1,3-thiazolidin-4-one

C26H24N2O3S (444.1508)


   

Alpha-D-Xylopyranosyl-(1->3)-Alpha-D-Xylopyranosyl-(1->3)-Beta-D-Glucopyranose

Alpha-D-Xylopyranosyl-(1->3)-Alpha-D-Xylopyranosyl-(1->3)-Beta-D-Glucopyranose

C16H28O14 (444.1479)


   

4-(dimethylamino)-6,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4a,5,5a,11a-tetrahydro-4H-tetracene-2-carboxamide

4-(dimethylamino)-6,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4a,5,5a,11a-tetrahydro-4H-tetracene-2-carboxamide

C22H24N2O8 (444.1533)


   

N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-1-(1H-imidazol-5-ylsulfonyl)-3-piperidinecarboxamide

N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-1-(1H-imidazol-5-ylsulfonyl)-3-piperidinecarboxamide

C20H24N6O4S (444.158)


   

Glc(b1-2)Xyl(b1-2)b-Xyl

Glc(b1-2)Xyl(b1-2)b-Xyl

C16H28O14 (444.1479)


   

4-(Dimethylamino)-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

4-(Dimethylamino)-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

C22H24N2O8 (444.1533)


   

2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

C21H30Cl2N2O4 (444.1583)


   

[(3aR,4R,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

[(3aR,4R,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

C27H22F2N2O2 (444.1649)


   

[(3aS,4S,9bS)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

[(3aS,4S,9bS)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

C27H22F2N2O2 (444.1649)


   

[(3aR,4S,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

[(3aR,4S,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone

C27H22F2N2O2 (444.1649)


   
   
   
   
   
   
   

alpha-Kdo-CH2OH-(2->4)-alpha-Kdo

alpha-Kdo-CH2OH-(2->4)-alpha-Kdo

C16H28O14 (444.1479)


   

alpha-Kdo-(2->4)-alpha-Kdo-CH2OH

alpha-Kdo-(2->4)-alpha-Kdo-CH2OH

C16H28O14 (444.1479)


   

Xyl(a1-3)Xyl(a1-3)Glc

Xyl(a1-3)Xyl(a1-3)Glc

C16H28O14 (444.1479)


   

4-(2-carboxyethyl)-7a-methyl-1-oxo-octahydro-1H-indene-5-carboxylic acid glucuronide

4-(2-carboxyethyl)-7a-methyl-1-oxo-octahydro-1H-indene-5-carboxylic acid glucuronide

C20H28O11 (444.1632)


   

Glc(b1-2)Xyl(b1-2)Xyl

Glc(b1-2)Xyl(b1-2)Xyl

C16H28O14 (444.1479)


   

Xyl(a1-4)Xyl(a1-6)Glc

Xyl(a1-4)Xyl(a1-6)Glc

C16H28O14 (444.1479)


   

Xylf(a1-3)Xylf(a1-3)Glc

Xylf(a1-3)Xylf(a1-3)Glc

C16H28O14 (444.1479)


   

Araf(a1-5)Araf(a1-4)Glc

Araf(a1-5)Araf(a1-4)Glc

C16H28O14 (444.1479)


   

Ara(a1-2)Glc(b1-2)a-Ara

Ara(a1-2)Glc(b1-2)a-Ara

C16H28O14 (444.1479)


   

Xyl(a1-3)Xyl(a1-3)a-Glc

Xyl(a1-3)Xyl(a1-3)a-Glc

C16H28O14 (444.1479)


   

Xyl(b1-4)Ara(a1-6)b-Glc

Xyl(b1-4)Ara(a1-6)b-Glc

C16H28O14 (444.1479)


   

Ara(a1-2)Ara(a1-4)b-Glc

Ara(a1-2)Ara(a1-4)b-Glc

C16H28O14 (444.1479)


   

Xyl(b1-2)Ara(a1-6)b-Glc

Xyl(b1-2)Ara(a1-6)b-Glc

C16H28O14 (444.1479)


   

Araf(a1-5)Araf(a1-4)b-Glc

Araf(a1-5)Araf(a1-4)b-Glc

C16H28O14 (444.1479)


   

Xylf(a1-3)Xylf(a1-3)b-Glc

Xylf(a1-3)Xylf(a1-3)b-Glc

C16H28O14 (444.1479)


   

D-mannopyranosyl-(1->5)-D-arabinofuranosyl-(1->2)-D-arabinofuranose

D-mannopyranosyl-(1->5)-D-arabinofuranosyl-(1->2)-D-arabinofuranose

C16H28O14 (444.1479)


   

Xyl(b1-2)[Xyl(b1-3)]b-Glc

Xyl(b1-2)[Xyl(b1-3)]b-Glc

C16H28O14 (444.1479)


   

Ara(a1-2)[Glc(b1-3)]a-Ara

Ara(a1-2)[Glc(b1-3)]a-Ara

C16H28O14 (444.1479)


   

D-Manp-(1->2)-D-Araf-(1->5)-D-Araf

D-Manp-(1->2)-D-Araf-(1->5)-D-Araf

C16H28O14 (444.1479)


   

Araf(a1-2)[Glc(b1-3)]a-Ara

Araf(a1-2)[Glc(b1-3)]a-Ara

C16H28O14 (444.1479)


   

Xyl(b1-2)[Xyl(b1-3)]Glc

Xyl(b1-2)[Xyl(b1-3)]Glc

C16H28O14 (444.1479)


   

Xyl(b1-2)[Xyl(b1-4)]b-Glc

Xyl(b1-2)[Xyl(b1-4)]b-Glc

C16H28O14 (444.1479)


   

Xyl(b1-2)[Glc(b1-3)]a-Ara

Xyl(b1-2)[Glc(b1-3)]a-Ara

C16H28O14 (444.1479)


   

Xyl(b1-2)[Xyl(b1-4)]Glc

Xyl(b1-2)[Xyl(b1-4)]Glc

C16H28O14 (444.1479)


   

Xyl(b1-4)[Ara(a1-6)]b-Glc

Xyl(b1-4)[Ara(a1-6)]b-Glc

C16H28O14 (444.1479)


   

7-[[2-(2,5-Dioxo-4-phenylimidazolidin-4-yl)phenyl]methyl]-1,3-dimethylpurine-2,6-dione

7-[[2-(2,5-Dioxo-4-phenylimidazolidin-4-yl)phenyl]methyl]-1,3-dimethylpurine-2,6-dione

C23H20N6O4 (444.1546)


   

(4R,4aR,5R,5aR,6S,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

(4R,4aR,5R,5aR,6S,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

C22H24N2O8 (444.1533)


   

(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid

(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid

C22H24N2O8 (444.1533)


   

(1r,4r,5r,6r,7r,8r,11r,13s,16s,17s,18s,19r)-4,5,6,7,8,16,17-heptahydroxy-6-(hydroxymethyl)-14,18-dimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-9-one

(1r,4r,5r,6r,7r,8r,11r,13s,16s,17s,18s,19r)-4,5,6,7,8,16,17-heptahydroxy-6-(hydroxymethyl)-14,18-dimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-9-one

C20H28O11 (444.1632)


   

(2r,3r,4s,5s,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

methyl 5-ethenyl-4-(4-methoxy-4-oxobut-1-en-1-yl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl 5-ethenyl-4-(4-methoxy-4-oxobut-1-en-1-yl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C20H28O11 (444.1632)


   

1-(4-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

1-(4-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

C20H28O11 (444.1632)


   

1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}phenyl)ethanone

1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}phenyl)ethanone

C20H28O11 (444.1632)


   

3-[3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

3-[3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

C20H28O11 (444.1632)


   

Doxytetracycline

Doxytetracycline

C22H24N2O8 (444.1533)


-

   

11144737

NA

C20H28O11 (444.1632)


{"Ingredient_id": "HBIN000288","Ingredient_name": "11144737","Alias": "NA","Ingredient_formula": "C20H28O11","Ingredient_Smile": "COC(=O)CC=CC1C(C(OC=C1C(=O)OC)OC2C(C(C(C(O2)CO)O)O)O)C=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "636","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4'-hydroxyacetophenone,8ci; o-[alpha-l-rhamnopyranosyl-(1→2)-beta-d-glucopyranoside]

NA

C20H28O11 (444.1632)


{"Ingredient_id": "HBIN010504","Ingredient_name": "4'-hydroxyacetophenone,8ci; o-[alpha-l-rhamnopyranosyl-(1\u21922)-beta-d-glucopyranoside]","Alias": "NA","Ingredient_formula": "C20H28O11","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7826","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C20H28O11 (444.1632)


   

11,12,16-trimethyl (1s,12s,13r)-6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

11,12,16-trimethyl (1s,12s,13r)-6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

C22H24N2O8 (444.1533)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl (2s)-2-phenylpropanoate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl (2s)-2-phenylpropanoate

C20H28O11 (444.1632)


   

7-methyl-1-[(3,4,5-trihydroxy-6-{[(3-oxobutanoyl)oxy]methyl}oxan-2-yl)oxy]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

7-methyl-1-[(3,4,5-trihydroxy-6-{[(3-oxobutanoyl)oxy]methyl}oxan-2-yl)oxy]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C20H28O11 (444.1632)


   

(2r,3r,4s,5r,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl 2-phenylpropanoate

3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl 2-phenylpropanoate

C20H28O11 (444.1632)


   

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C20H28O11 (444.1632)


   

(2r,3r,4s,5s,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

(2r,3r,4s,5r,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

C20H28O11 (444.1632)


   

(1r,4ar,7s,7as)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(3-oxobutanoyl)oxy]methyl}oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1r,4ar,7s,7as)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(3-oxobutanoyl)oxy]methyl}oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C20H28O11 (444.1632)


   

methyl (4s,5r,6s)-5-ethenyl-4-[(1e)-4-methoxy-4-oxobut-1-en-1-yl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl (4s,5r,6s)-5-ethenyl-4-[(1e)-4-methoxy-4-oxobut-1-en-1-yl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C20H28O11 (444.1632)


   

3-[(2r,3s)-3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

3-[(2r,3s)-3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

C20H28O11 (444.1632)


   

(4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

(4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H24N2O8 (444.1533)


   

4,5,6,7,8,16,17-heptahydroxy-6-(hydroxymethyl)-14,18-dimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-9-one

4,5,6,7,8,16,17-heptahydroxy-6-(hydroxymethyl)-14,18-dimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-9-one

C20H28O11 (444.1632)


   

1-(4-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

1-(4-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone

C20H28O11 (444.1632)


   

4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H24N2O8 (444.1533)


   

(4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

(4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H24N2O8 (444.1533)


   

2-{[3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

2-{[3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C20H28O11 (444.1632)


   

11,12,16-trimethyl (1r,12s,13r)-6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

11,12,16-trimethyl (1r,12s,13r)-6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

C22H24N2O8 (444.1533)


   

6-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-3-[2-(4-hydroxyphenyl)ethenyl]cyclohept-2-en-1-one

6-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-3-[2-(4-hydroxyphenyl)ethenyl]cyclohept-2-en-1-one

C27H24O6 (444.1573)


   

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(4-ethenyl-2-methoxyphenoxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(4-ethenyl-2-methoxyphenoxy)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl (2r)-2-(acetyloxy)-3-hydroxy-3-methylbutanoate

(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl (2r)-2-(acetyloxy)-3-hydroxy-3-methylbutanoate

C20H28O11 (444.1632)


   

3-[(2r,3s)-3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

3-[(2r,3s)-3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid

C20H28O11 (444.1632)


   

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C20H28O11 (444.1632)


   

11,12,16-trimethyl 6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

11,12,16-trimethyl 6,8-dioxa-11,20-diazapentacyclo[10.5.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosa-2(10),3,5(9),16-tetraene-11,12,16-tricarboxylate

C22H24N2O8 (444.1533)


   

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-hydroxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C20H28O11 (444.1632)


   

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(4-ethenyl-2-methoxyphenoxy)oxane-3,4,5-triol

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(4-ethenyl-2-methoxyphenoxy)oxane-3,4,5-triol

C20H28O11 (444.1632)


   

(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl 2-(acetyloxy)-3-hydroxy-3-methylbutanoate

(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl 2-(acetyloxy)-3-hydroxy-3-methylbutanoate

C20H28O11 (444.1632)


   

(5s,6s)-6-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-3-[(1e)-2-(4-hydroxyphenyl)ethenyl]cyclohept-2-en-1-one

(5s,6s)-6-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-3-[(1e)-2-(4-hydroxyphenyl)ethenyl]cyclohept-2-en-1-one

C27H24O6 (444.1573)